83 related articles for article (PubMed ID: 9036602)
1. [Fat-soluble vitamins E and A in the tumor tissue and in the blood of patients with renal-cell cancer].
Nikiforova NV; Chumakov AM; Kirpatovskiĭ VI; Komarova VA
Urol Nefrol (Mosk); 1996; (6):23-7. PubMed ID: 9036602
[TBL] [Abstract][Full Text] [Related]
2. [Content of vitamins E and A in tumor tissue in kidney cancer].
Nikiforova NV; Kirpatovskiĭ VI; Chumakov AM; Darenkov AF
Biull Eksp Biol Med; 1993 Mar; 115(3):290-3. PubMed ID: 8054629
[TBL] [Abstract][Full Text] [Related]
3. Liposoluble vitamins E and A in human renal cortex and renal cell carcinomas.
Nikiforova NV; Kirpatovsky VI; Darenkov AF; Chumakov AM; Sevrukov EA; Darenkov SP
Nephron; 1995; 69(4):449-53. PubMed ID: 7777111
[TBL] [Abstract][Full Text] [Related]
4. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
[TBL] [Abstract][Full Text] [Related]
5. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
Shvarts O; Seligson D; Lam J; Shi T; Horvath S; Figlin R; Belldegrun A; Pantuck AJ
J Urol; 2005 Mar; 173(3):725-8. PubMed ID: 15711252
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
8. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
9. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
Hafez KS; Novick AC; Butler BP
J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
11. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z
Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573
[TBL] [Abstract][Full Text] [Related]
12. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
13. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer.
Mantur M; Kemona H; Kozłowski R; Kemona-Chetnik I
Neoplasma; 2003; 50(4):262-5. PubMed ID: 12937838
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
15. Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma.
Eroğlu M; Unsal A; Bakirtaş H; Tekdoğan U; Ataoğlu O; Balbay MD
Scand J Urol Nephrol; 2005; 39(3):222-5. PubMed ID: 16118094
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
17. Incidence rate of satellite tumors in renal cell carcinoma.
Kinouchi T; Mano M; Saiki S; Meguro N; Maeda O; Kuroda M; Usami M; Kotake T
Cancer; 1999 Dec; 86(11):2331-6. PubMed ID: 10590375
[TBL] [Abstract][Full Text] [Related]
18. Identification of nuclear matrix protein alterations associated with renal cell carcinoma.
Konety BR; Nangia AK; Nguyen TS; Veitmeier BN; Dhir R; Acierno JS; Becich MJ; Hrebinko RL; Getzenberg RH
J Urol; 1998 Apr; 159(4):1359-63. PubMed ID: 9507884
[TBL] [Abstract][Full Text] [Related]
19. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
20. Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma.
Sartini D; Muzzonigro G; Milanese G; Pierella F; Rossi V; Emanuelli M
J Urol; 2006 Nov; 176(5):2248-54. PubMed ID: 17070307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]